文献速递肝病炎症性肠病

原发性硬化性胆管炎中必需营养素肠道微生物代谢的改变

Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis.
PubMed 文献 · Gastroenterology · 2020-12-31

该研究对挪威和德国两个队列的粪便DNA进行宏基因组测序,共纳入136例PSC患者、158例健康对照和93例无PSC的IBD患者。PSC患者微生物基因数少于健康对照,维生素B6合成和支链氨基酸合成相关基因丰度显著改变,血浆维生素B6和支链氨基酸浓度降低且与无肝移植生存期缩短相关。PSC伴或不伴IBD患者间无差异。

要点

  • PSC患者肠道微生物基因数显著少于健康对照(P < .0001)。
  • PSC患者维生素B6合成和支链氨基酸合成相关基因丰度改变(Qfdr < .05)。
  • 血浆维生素B6和支链氨基酸降低与无肝移植生存期缩短相关(log-rank P < .001)。

核心结论

  • PSC患者肠道微生物组功能与健康对照存在显著差异,涉及必需营养素的微生物代谢。
  • 相关循环代谢物改变与疾病进程相关,提示微生物功能可能参与PSC疾病过程。

研究设计与样本

  • 对两个队列(挪威和德国)的粪便DNA进行宏基因组鸟枪法测序,共136例PSC患者(58%伴IBD)、158例健康对照和93例无PSC的IBD患者。
  • 对独立PSC患者和对照血浆进行靶向代谢组学分析。

主要发现

  • PSC患者微生物基因数少于健康对照(P < .0001)。
  • 与健康对照相比,PSC患者中梭菌属物种富集且患病率增加,真杆菌属和Ruminococcus obeum等耗竭。
  • PSC患者维生素B6合成和支链氨基酸合成相关基因丰度存在显著差异(Qfdr < .05)。
  • 独立PSC患者血浆维生素B6和支链氨基酸浓度降低(P < .0001),与无肝移植生存期缩短强相关(log-rank P < .001)。
  • 伴或不伴IBD的PSC患者间未检测到分类学或功能差异。

临床怎么用

  • PSC患者可考虑关注维生素B6和支链氨基酸相关微生物代谢功能及循环水平。
  • 血浆维生素B6和支链氨基酸水平可能与PSC无肝移植生存期相关,值得进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: To influence host and disease phenotype, compositional microbiome changes, which have been demonstrated in patients with primary sclerosing cholangitis (PSC), must be accompanied by functional changes. We therefore aimed to characterize the genetic potential of the gut microbiome in patients with PSC compared with healthy controls (HCs) and patients with inflammatory bowel disease (IBD). METHODS: Fecal DNA from 2 cohorts (1 Norwegian and 1 German), in total comprising 136 patients with PSC (58% with IBD), 158 HCs, and 93 patients with IBD without PSC, were subjected to metagenomic shotgun sequencing, generating 17 billion paired-end sequences, which were processed using HUMAnN2 and MetaPhlAn2, and analyzed using generalized linear models and random effects meta-analyses. RESULTS: Patients with PSC had fewer microbial genes compared with HCs (P < .0001). Compared with HCs, patients with PSC showed enrichment and increased prevalence of Clostridium species and a depletion of, for example, Eubacterium spp and Ruminococcus obeum. Patients with PSC showed marked differences in the abundance of genes related to vitamin B6 synthesis and branched-chain amino acid synthesis (Qfdr < .05). Targeted metabolomics of plasma from an independent set of patients with PSC and controls found reduced concentrations of vitamin B6 and branched-chain amino acids in PSC (P < .0001), which strongly associated with reduced liver transplantation-free survival (log-rank P < .001). No taxonomic or functional differences were detected between patients with PSC with and without IBD. CONCLUSIONS: The gut microbiome in patients with PSC exhibits large functional differences compared with that in HCs, including microbial metabolism of essential nutrients. Alterations in related circulating metabolites associated with disease course, suggesting that microbial functions may be relevant for the disease process in PSC.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Kummen M, Thingholm LB, Rühlemann MC, et al. Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis. Gastroenterology. 2020. PMID: 33387530. doi:10.1053/j.gastro.2020.12.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。